0.7800
-0.0263
(-3.26%)
At close: January 10 at 4:00:00 PM EST
0.7850
+0.01
+(0.64%)
After hours: January 10 at 4:19:16 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-18,243.5210
-24,738.6030
-17,621.4980
-14,284.9240
-13,935.0860
Investing Cash Flow
-8.6640
-71.2140
-59.7350
-83.7960
-2,337.2500
Financing Cash Flow
8,029.1470
10,593.3770
6.4260
25,677.9110
41,589.5290
End Cash Position
1,488.2810
6,737.6290
20,954.0690
38,628.8760
27,319.6850
Capital Expenditure
-77.3184
-71.3830
-59.7350
-83.7960
-2,337.2500
Issuance of Capital Stock
8,029.1470
10,593.3770
6.4260
25,677.9110
41,589.5290
Free Cash Flow
-18,253.5210
-24,809.9860
-17,681.2330
-14,368.7200
-16,272.3360
12/31/2020 - 3/29/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GLYC GlycoMimetics, Inc.
0.2650
-4.26%
GRI GRI Bio, Inc.
0.7625
+3.80%
TVGN Tevogen Bio Holdings Inc.
1.4500
+12.40%
CDIO Cardio Diagnostics Holdings, Inc.
0.6710
-8.11%
BIVI BioVie Inc.
2.2100
-6.36%
RNAZ TransCode Therapeutics, Inc.
3.2800
-4.37%
QNRX Quoin Pharmaceuticals, Ltd.
0.6215
-0.26%
LYRA Lyra Therapeutics, Inc.
0.1955
-2.59%
VRAX Virax Biolabs Group Limited
2.4200
+3.42%
ENSC Ensysce Biosciences, Inc.
7.49
-5.31%